Company Filing History:
Years Active: 2008-2025
Title: The Innovations of Peter Greasley
Introduction
Peter Greasley is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of medicine, particularly in the treatment of endothelin-related diseases. With a total of 4 patents to his name, Greasley continues to push the boundaries of innovation in healthcare.
Latest Patents
One of Greasley's latest patents involves the combination of zibotentan and dapagliflozin for the treatment of endothelin-related diseases. This patent highlights the use of the endothelin receptor antagonist (ERA) zibotentan in conjunction with the sodium-dependent glucose cotransporter 2 (SGLT-2) inhibitor dapagliflozin. This combination aims to provide effective treatment options for patients suffering from specific endothelin-related conditions.
Career Highlights
Greasley is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to collaborate with other experts in the field and contribute to groundbreaking research and development.
Collaborations
One of his notable coworkers is Robert Menzies, with whom he has likely shared insights and expertise in their respective areas of research.
Conclusion
Peter Greasley exemplifies the spirit of innovation in the medical field through his patents and collaborations. His work continues to impact the treatment of endothelin-related diseases, showcasing the importance of research and development in healthcare.